Endo Provides Top-Line Results from Phase 2 Study of Collage

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum...

Related Keywords

Canada , Dublin , Ireland , Texas , United States , Canadian , Jamesp Tursi , Josephm Caporusso , , Prnewswire Endo International , Exchange Commission , Copies Of The Company , Linkedin , Company Investor Relations Department , Endo International , Global Research Development At Endo , Foot Function Index , Spain Scale , Clinician Global Impression , Executive Vice President , Global Research , Restriction Scale , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Investor Relations Department , Endo International Plc ,